Clinical Trial Update: Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating AAVCAGsCD59 for advanced dry age-related macular degeneration has completed. The study was sponsored by Janssen Research & Dev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• AAVCAGsCD59

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Dry Age-related Macular Degeneration | Phase 1 | Status: COMPLETED